Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index

Jenny J. Choi, Mary Digiorgi, Luca Milone, Beth Schrope, Lorraine Olivera-Rivera, Amna Daud, Dan Davis, Marc Bessler

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Background: The current National Institutes of Health guidelines have recommended bariatric surgery for patients with a body mass index (BMI) >40 kg/m 2 or BMI >35 kg/m 2 with significant co-morbidities. However, some preliminary studies have shown that patients with a BMI that does not meet these criteria could also experience similar weight loss and the benefits associated with it. Methods: An institutional review board-approved protocol was obtained to study the effectiveness of laparoscopic adjustable gastric banding in patients with a low BMI. A total of 66 patients with a BMI of 30-35 kg/m 2 and co-morbidities (n = 22) or a BMI of 35-40 kg/m 2 without comorbidities (n = 44) underwent laparoscopic adjustable gastric banding. These patients were compared with 438 standard patients who had undergone laparoscopic adjustable gastric banding who met the National Institutes of Health criteria for bariatric surgery. The excess weight loss at 3, 6, 12, and 18 months and the status of their co-morbidities were compared between the 2 groups. Results: The average BMI for the study group was 36.1 ± 2.6 kg/m 2 compared with 46.0 ± 7.3 kg/m 2 for the control group. Both groups had significant co-morbidities, including hypertension, diabetes, hyperlipidemia, arthritis, gastroesophageal reflux disease, stress incontinence, and obstructive sleep apnea. The mean percentage of excess weight loss was 20.3% ± 9.0%, 28.5% ± 14.0%, 44.7% ± 19.3%, and 42.2% ± 33.7% at 3, 6, 12, and 18 months, respectively. This was not significantly different from the excess weight loss in the control group, except for at 12 months. Both groups showed similar improvement of most co-morbidities. Conclusion: Moderately obese patients whose BMI is less than the current guidelines for bariatric surgery will have similar weight loss and associated benefits. Laparoscopic adjustable gastric banding is a safe and effective treatment for patients with a BMI of 30-35 kg/m 2 .

Original languageEnglish (US)
Pages (from-to)367-371
Number of pages5
JournalSurgery for Obesity and Related Diseases
Volume6
Issue number4
DOIs
StatePublished - Jul 2010
Externally publishedYes

Fingerprint

Stomach
Body Mass Index
Weight Loss
Bariatric Surgery
Morbidity
National Institutes of Health (U.S.)
Guidelines
Control Groups
Research Ethics Committees
Obstructive Sleep Apnea
Gastroesophageal Reflux
Hyperlipidemias
Arthritis
Comorbidity
Hypertension

ASJC Scopus subject areas

  • Surgery
  • Medicine(all)

Cite this

Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. / Choi, Jenny J.; Digiorgi, Mary; Milone, Luca; Schrope, Beth; Olivera-Rivera, Lorraine; Daud, Amna; Davis, Dan; Bessler, Marc.

In: Surgery for Obesity and Related Diseases, Vol. 6, No. 4, 07.2010, p. 367-371.

Research output: Contribution to journalArticle

Choi, JJ, Digiorgi, M, Milone, L, Schrope, B, Olivera-Rivera, L, Daud, A, Davis, D & Bessler, M 2010, 'Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index', Surgery for Obesity and Related Diseases, vol. 6, no. 4, pp. 367-371. https://doi.org/10.1016/j.soard.2009.09.021
Choi, Jenny J. ; Digiorgi, Mary ; Milone, Luca ; Schrope, Beth ; Olivera-Rivera, Lorraine ; Daud, Amna ; Davis, Dan ; Bessler, Marc. / Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index. In: Surgery for Obesity and Related Diseases. 2010 ; Vol. 6, No. 4. pp. 367-371.
@article{bff2ee07947f44b4af2ea648d5e0d8c4,
title = "Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index",
abstract = "Background: The current National Institutes of Health guidelines have recommended bariatric surgery for patients with a body mass index (BMI) >40 kg/m 2 or BMI >35 kg/m 2 with significant co-morbidities. However, some preliminary studies have shown that patients with a BMI that does not meet these criteria could also experience similar weight loss and the benefits associated with it. Methods: An institutional review board-approved protocol was obtained to study the effectiveness of laparoscopic adjustable gastric banding in patients with a low BMI. A total of 66 patients with a BMI of 30-35 kg/m 2 and co-morbidities (n = 22) or a BMI of 35-40 kg/m 2 without comorbidities (n = 44) underwent laparoscopic adjustable gastric banding. These patients were compared with 438 standard patients who had undergone laparoscopic adjustable gastric banding who met the National Institutes of Health criteria for bariatric surgery. The excess weight loss at 3, 6, 12, and 18 months and the status of their co-morbidities were compared between the 2 groups. Results: The average BMI for the study group was 36.1 ± 2.6 kg/m 2 compared with 46.0 ± 7.3 kg/m 2 for the control group. Both groups had significant co-morbidities, including hypertension, diabetes, hyperlipidemia, arthritis, gastroesophageal reflux disease, stress incontinence, and obstructive sleep apnea. The mean percentage of excess weight loss was 20.3{\%} ± 9.0{\%}, 28.5{\%} ± 14.0{\%}, 44.7{\%} ± 19.3{\%}, and 42.2{\%} ± 33.7{\%} at 3, 6, 12, and 18 months, respectively. This was not significantly different from the excess weight loss in the control group, except for at 12 months. Both groups showed similar improvement of most co-morbidities. Conclusion: Moderately obese patients whose BMI is less than the current guidelines for bariatric surgery will have similar weight loss and associated benefits. Laparoscopic adjustable gastric banding is a safe and effective treatment for patients with a BMI of 30-35 kg/m 2 .",
author = "Choi, {Jenny J.} and Mary Digiorgi and Luca Milone and Beth Schrope and Lorraine Olivera-Rivera and Amna Daud and Dan Davis and Marc Bessler",
year = "2010",
month = "7",
doi = "10.1016/j.soard.2009.09.021",
language = "English (US)",
volume = "6",
pages = "367--371",
journal = "Surgery for Obesity and Related Diseases",
issn = "1550-7289",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - Outcomes of laparoscopic adjustable gastric banding in patients with low body mass index

AU - Choi, Jenny J.

AU - Digiorgi, Mary

AU - Milone, Luca

AU - Schrope, Beth

AU - Olivera-Rivera, Lorraine

AU - Daud, Amna

AU - Davis, Dan

AU - Bessler, Marc

PY - 2010/7

Y1 - 2010/7

N2 - Background: The current National Institutes of Health guidelines have recommended bariatric surgery for patients with a body mass index (BMI) >40 kg/m 2 or BMI >35 kg/m 2 with significant co-morbidities. However, some preliminary studies have shown that patients with a BMI that does not meet these criteria could also experience similar weight loss and the benefits associated with it. Methods: An institutional review board-approved protocol was obtained to study the effectiveness of laparoscopic adjustable gastric banding in patients with a low BMI. A total of 66 patients with a BMI of 30-35 kg/m 2 and co-morbidities (n = 22) or a BMI of 35-40 kg/m 2 without comorbidities (n = 44) underwent laparoscopic adjustable gastric banding. These patients were compared with 438 standard patients who had undergone laparoscopic adjustable gastric banding who met the National Institutes of Health criteria for bariatric surgery. The excess weight loss at 3, 6, 12, and 18 months and the status of their co-morbidities were compared between the 2 groups. Results: The average BMI for the study group was 36.1 ± 2.6 kg/m 2 compared with 46.0 ± 7.3 kg/m 2 for the control group. Both groups had significant co-morbidities, including hypertension, diabetes, hyperlipidemia, arthritis, gastroesophageal reflux disease, stress incontinence, and obstructive sleep apnea. The mean percentage of excess weight loss was 20.3% ± 9.0%, 28.5% ± 14.0%, 44.7% ± 19.3%, and 42.2% ± 33.7% at 3, 6, 12, and 18 months, respectively. This was not significantly different from the excess weight loss in the control group, except for at 12 months. Both groups showed similar improvement of most co-morbidities. Conclusion: Moderately obese patients whose BMI is less than the current guidelines for bariatric surgery will have similar weight loss and associated benefits. Laparoscopic adjustable gastric banding is a safe and effective treatment for patients with a BMI of 30-35 kg/m 2 .

AB - Background: The current National Institutes of Health guidelines have recommended bariatric surgery for patients with a body mass index (BMI) >40 kg/m 2 or BMI >35 kg/m 2 with significant co-morbidities. However, some preliminary studies have shown that patients with a BMI that does not meet these criteria could also experience similar weight loss and the benefits associated with it. Methods: An institutional review board-approved protocol was obtained to study the effectiveness of laparoscopic adjustable gastric banding in patients with a low BMI. A total of 66 patients with a BMI of 30-35 kg/m 2 and co-morbidities (n = 22) or a BMI of 35-40 kg/m 2 without comorbidities (n = 44) underwent laparoscopic adjustable gastric banding. These patients were compared with 438 standard patients who had undergone laparoscopic adjustable gastric banding who met the National Institutes of Health criteria for bariatric surgery. The excess weight loss at 3, 6, 12, and 18 months and the status of their co-morbidities were compared between the 2 groups. Results: The average BMI for the study group was 36.1 ± 2.6 kg/m 2 compared with 46.0 ± 7.3 kg/m 2 for the control group. Both groups had significant co-morbidities, including hypertension, diabetes, hyperlipidemia, arthritis, gastroesophageal reflux disease, stress incontinence, and obstructive sleep apnea. The mean percentage of excess weight loss was 20.3% ± 9.0%, 28.5% ± 14.0%, 44.7% ± 19.3%, and 42.2% ± 33.7% at 3, 6, 12, and 18 months, respectively. This was not significantly different from the excess weight loss in the control group, except for at 12 months. Both groups showed similar improvement of most co-morbidities. Conclusion: Moderately obese patients whose BMI is less than the current guidelines for bariatric surgery will have similar weight loss and associated benefits. Laparoscopic adjustable gastric banding is a safe and effective treatment for patients with a BMI of 30-35 kg/m 2 .

UR - http://www.scopus.com/inward/record.url?scp=78149261600&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=78149261600&partnerID=8YFLogxK

U2 - 10.1016/j.soard.2009.09.021

DO - 10.1016/j.soard.2009.09.021

M3 - Article

VL - 6

SP - 367

EP - 371

JO - Surgery for Obesity and Related Diseases

JF - Surgery for Obesity and Related Diseases

SN - 1550-7289

IS - 4

ER -